Dublin, July 29, 2024 (GLOBE NEWSWIRE) — The “Microbiology Reagent Market – Global Industry Size, Share, Trends, Opportunities and Forecast, 2019-2029” report has been added to ResearchAndMarkets.com Dedication.
The global microbial reagents market will be valued at USD 2.93 billion in 2023 and is expected to grow steadily during the forecast period, with a compound annual growth rate of 5.94% by 2029.
Key market drivers
High infectious disease burden
The heavy burden of infectious diseases is a major driver of the growing demand for microbiology reagents. Infectious diseases require accurate and rapid diagnosis for effective treatment and control. Microbiology reagents play a vital role in diagnostic tests such as PCR, immunoassays, and culture-based methods. As infectious diseases continue to pose a threat to global health, the demand for microbial reagents for diagnostic purposes continues to increase. The emergence of new infectious agents and the re-emergence of previously controlled diseases, such as tuberculosis and antibiotic-resistant bacteria, create an ongoing need for advanced microbiological reagents. These reagents enable researchers and clinicians to identify and characterize these evolving pathogens.
Advances in Life Sciences and Biotechnology
Advances in the fields of life sciences and biotechnology have greatly increased the demand for microbial reagents. The field of genomics is rapidly expanding, and microbiology reagents are critical for DNA and RNA isolation, PCR, and sequencing. As genomic research becomes more common in various life science disciplines, including microbiology, the need for high-quality reagents to manipulate and analyze genetic material increases. Microbiome research explores the diverse communities of microorganisms living in humans, animals, and the environment and relies heavily on microbiological reagents. Researchers use these reagents for DNA extraction, 16S rRNA sequencing, and metagenomic analysis to provide a deeper understanding of the role of the microbiome in health and disease. Biotechnology and pharmaceutical companies require microbial reagents for drug discovery, particularly in the development of antibiotics, antivirals, and vaccines. These reagents are critical for studying the mechanisms of microbial pathogens and screening potential therapeutic compounds. Vaccine development relies heavily on microbial reagents for antigen production, vaccine formulation, and quality control. As vaccine research and production continue to expand, so does the need for reagents that facilitate these processes.
Increase in elderly population
Because of their weakened immune systems, older adults are more susceptible to infectious diseases and often suffer from multiple chronic conditions. This high degree of vulnerability requires more frequent and more precise diagnostic testing for infectious pathogens using microbial reagents. Respiratory tract infections, including pneumonia, are common in older adults. These conditions often require microbiology testing to identify the causative agent, such as bacteria or viruses, so that appropriate treatment can be given with antibiotics or antiviral drugs. Older adults often live in long-term care facilities, which can be hot spots for infectious disease outbreaks. In this situation, ongoing surveillance and microbiological testing are essential to control and prevent the spread of infection. Urinary tract infections are common in older adults. Accurate diagnosis through microbiological reagents is essential for correct treatment and prevention of complications such as kidney infection. Many older adults have chronic medical conditions that make them more susceptible to infection. Microbiology reagents are critical for diagnosing and treating infections that may exacerbate these pre-existing health problems. Immunosenescence is the natural aging of the immune system, making it less efficient at identifying and fighting pathogens. This emphasizes the importance of accurate and timely microbiological diagnosis for timely intervention.
Advanced product adoption rates rise
Advances in enzyme-linked immunoassays (ELISA), polymerase chain reaction (PCR) (including digital PCR and rtPCR), chromatography, single-cell technology, next-generation sequencing (NGS) and flow cytometry have helped The life science reagent market driving the healthcare industry. These technologies have revolutionized disease diagnosis and treatment monitoring, improving sensitivity, specificity, precision, and shortening incubation times.
Integration of various diagnostic technologies into a single system, development of high-throughput automated immunoassays, and advancements in point-of-care (POC) instrumentation have further driven the demand for in vitro diagnostic reagents. Genomics and proteomics research paves the way for newer genetic and protein biomarkers, allowing more accurate diagnosis of cancer and genetic diseases and personalized medicine. The application of cell and tissue culture in monoclonal antibody production, drug development, vaccines, enzymes, growth hormones and stem cell therapies has contributed to the growing demand for life science reagents.
Main market challenges
- High cost of reagents
- Strict regulatory framework
Key market trends
emerging infectious diseases
The continued emergence of new infectious diseases and the re-emergence of previously controlled infectious diseases are likely to drive the demand for microbiology reagents. These reagents play a vital role in diagnosing and studying these pathogens. Microbiology reagents are critical for studying the biology, genetics, and epidemiology of emerging pathogens. Researchers use these reagents to understand the pathogen's characteristics, transmission mechanisms and potential resistance, helping to develop effective countermeasures. Governments and public health agencies stockpile microbiological reagents and diagnostic tests as part of their preparedness efforts. These reagents are critical for rapid response to outbreaks, ensuring diagnostic and surveillance capabilities are readily available. Continuous monitoring and surveillance of infectious diseases is critical for early detection and intervention. Microbiology reagents are used to test samples from patients, animals, and environmental sources to track the spread of disease and identify potential reservoirs. Rapid response to emerging infectious diseases and the re-emergence of controlled infectious diseases relies heavily on the availability and accessibility of microbiological reagents. These reagents are indispensable tools for diagnosing, researching and ultimately mitigating the impact of infectious disease outbreaks on public health and global security.
biotech innovation
The expanding field of biotechnology has stimulated demand for microbial reagents in areas such as bioprocessing and fermentation for biofuel and pharmaceutical production. Biotechnology companies are increasingly using microbial reagents to optimize bioprocessing technologies. These reagents help monitor and control microbial cultures used in the production of biopharmaceuticals, enzymes and other bio-based products. Precise control of microbial growth and metabolism is critical to maximizing yield and product quality. The field of biotechnology often requires the development of genetically modified microbial strains to increase product yields and develop new products. Microbiology reagents play a crucial role in characterizing and validating these engineered strains. Biotech companies involved in biofuel production often focus on sustainability. Microbiological reagents are used to monitor and maintain the environmental impact of production processes, ensuring they are environmentally friendly and comply with environmental regulations.
Major market players
- Thermo Fisher Scientific
- Danaher
- Merck
- Bio-Rad Laboratories
- bioMérieux
- QJ
- F.Hoffman-LaRoche
- dickinson becton
- Siemens Healthineers
- ACT gene
Key attributes:
| Report properties | detail |
| Number of pages | 180 |
| forecast period | 2023-2029 |
| Estimated market value in 2023 (USD) | $2.93 billion |
| Forecast market value by 2029 (USD) | $4.12 billion |
| CAGR | 5.9% |
| Coverage area | Global |
Report scope:
In this report, in addition to the industry trends detailed below, the global microbial reagents market is also divided into the following categories:
Microbiology Reagents Market, By Type:
- Detection reagent
- Staining reagents
- medium
- antibiotic solution
- others
Microbiology reagents market, by reagent type:
- Silica
- Agar powder
- Gelatin powder
- others
Microbial reagents market, by product type:
- Pathogen specific kits
- Universal kit
Microbial reagents market, by end-user industry:
- health care
- drug
- Food & Beverage
- agriculture
- cosmetic
- clinical microbiology
- academia
- others
For more information about this report, please visit https://www.researchandmarkets.com/r/2graiw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.
-
Global microbial reagent market
